Search research articles
Contact Us
Filters
Showing results (61-70 of 168) with videos related to
Page
of 17
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
October 18, 2000
Generation of tumor-reactive CTL against the tumor-associated antigen HER2 using retrovirally transduced dendritic cells derived from CD34+ hemopoietic progenitor cells
C Meyer zum Büschenfelde, N Nicklisch, S Rose-John, et al.
Annals of the New York Academy of Sciences
|
March 28, 2001
Cytokines and neurotrophins interact in normal and diseased states
U Otten, P März, K Heese, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 30, 1998
Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression
J W Oh, N J Van Wagoner, S Rose-John, et al.
Journal of Immunological Methods
|
September 9, 1996
Alternative assay procedures for cytokines and soluble receptors of the IL-6 family
B Oppmann, T Stoyan, M Fischer, et al.
Carcinogenesis
|
May 1, 1988
Differential effects of phorbol esters on c-fos and c-myc and ornithine decarboxylase gene expression in mouse skin in vivo
S Rose-John, G Fürstenberger, P Krieg, et al.
FEBS Letters
|
July 20, 1992
The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand
D Zohlnhöfer, L Graeve, S Rose-John, et al.
FEBS Letters
|
July 20, 1992
Soluble human interleukin-6-receptor modulates interleukin-6-dependent N-glycosylation of alpha 1-protease inhibitor secreted by HepG2 cells
A Mackiewicz, S Rose-John, H Schooltink, et al.
Leukemia
|
October 3, 2002
Murine stromal cells producing hyper-interleukin-6 and Flt3 ligand support expansion of early human hematopoietic progenitor cells without need of exogenous growth factors
U Keller, K S Götze, J Duyster, et al.
Journal of Immunological Methods
|
March 24, 1999
Immunoadhesins of interleukin-6 and the IL-6/soluble IL-6R fusion protein hyper-IL-6
T Jostock, G Blinn, C Renné, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 18, 2001
Hyper-IL-6 gene therapy reverses fulminant hepatic failure
N Hecht, O Pappo, D Shouval, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 168) with videos related to
Sort By:
Page
of 17
Journal of Immunology (Baltimore, Md. : 1950)
|
October 18, 2000
Generation of tumor-reactive CTL against the tumor-associated antigen HER2 using retrovirally transduced dendritic cells derived from CD34+ hemopoietic progenitor cells
C Meyer zum Büschenfelde, N Nicklisch, S Rose-John, et al.
Annals of the New York Academy of Sciences
|
March 28, 2001
Cytokines and neurotrophins interact in normal and diseased states
U Otten, P März, K Heese, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 30, 1998
Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression
J W Oh, N J Van Wagoner, S Rose-John, et al.
Journal of Immunological Methods
|
September 9, 1996
Alternative assay procedures for cytokines and soluble receptors of the IL-6 family
B Oppmann, T Stoyan, M Fischer, et al.
Carcinogenesis
|
May 1, 1988
Differential effects of phorbol esters on c-fos and c-myc and ornithine decarboxylase gene expression in mouse skin in vivo
S Rose-John, G Fürstenberger, P Krieg, et al.
FEBS Letters
|
July 20, 1992
The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand
D Zohlnhöfer, L Graeve, S Rose-John, et al.
FEBS Letters
|
July 20, 1992
Soluble human interleukin-6-receptor modulates interleukin-6-dependent N-glycosylation of alpha 1-protease inhibitor secreted by HepG2 cells
A Mackiewicz, S Rose-John, H Schooltink, et al.
Leukemia
|
October 3, 2002
Murine stromal cells producing hyper-interleukin-6 and Flt3 ligand support expansion of early human hematopoietic progenitor cells without need of exogenous growth factors
U Keller, K S Götze, J Duyster, et al.
Journal of Immunological Methods
|
March 24, 1999
Immunoadhesins of interleukin-6 and the IL-6/soluble IL-6R fusion protein hyper-IL-6
T Jostock, G Blinn, C Renné, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 18, 2001
Hyper-IL-6 gene therapy reverses fulminant hepatic failure
N Hecht, O Pappo, D Shouval, et al.
Page
of 17